Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-07

Clinical Trial Update: Buprenorphine Plus Baclofen to Increase Analgesia in Healthy Volunteers [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating buprenorphine plus baclofen to enhance analgesia in healthy volunteers was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Acute Pain, Analgesia | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2026-01-07